GK said in his EGM presentation that he expected NOX66 to have synergy with a wide range of radioligands. He would have data to back this up, given the association Noxopharm has with Professor Nat Lenzo of GenesisCare.
This raises an interesting point: would Novartis be happy for anyone to use NOX66, or might they try to grab it for themselves?
GK said in his EGM presentation that he expected NOX66 to have...
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $32.14M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.0¢ | $18.94K | 171.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 66800 | 1 |
View Market Depth
| Last trade - 14.48pm 08/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |